Affiliation:
1. Pain Management Research Institute, Kolling Institute, Royal North Shore Hospital St Leonards New South Wales Australia
2. Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
3. Discipline of Pharmacology, School of Pharmacy, Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
Abstract
AbstractThe neurotransmitter glycine is an agonist at the strychnine‐sensitive glycine receptors. In addition, it has recently been discovered to act at two new receptors, the excitatory glycine receptor and metabotropic glycine receptor. Glycine's neurotransmitter roles have been most extensively investigated in the spinal cord, where it is known to play essential roles in pain, itch, and motor function. In contrast, less is known about supraspinal glycinergic functions, and their contributions to pain circuits are largely unrecognized. As glycinergic neurons are absent from cortical regions, a clearer understanding of how supraspinal glycine modulates pain could reveal new pharmacological targets. This review aims to synthesize the published research on glycine's role in the adult brain, highlighting regions where glycine signaling may modulate pain responses. This was achieved through a scoping review methodology identifying several key regions of supraspinal pain circuitry where glycine signaling is involved. Therefore, this review unveils critical research gaps for supraspinal glycine's potential roles in pain and pain‐associated responses, encouraging researchers to consider glycinergic neurotransmission more widely when investigating neural mechanisms of pain.image